Condition: Cholangiocarcinoma, Intrahepatic
Intervention: Drug: combined therapy using oxaliplatin and gemcitabine chemotherapy, Lenvatinib and PD1 antibody (JS001)
Sponsor: Shanghai Zhongshan Hospital
Recruiting
55474 items (55474 unread) in 74 feeds